Climb Bio Inc
CLYM
$10.85-1.99%
Delayed · as of Oct 2, 2026, 1:45 PM ET
Mkt cap
$85.82M
EV/Sales
6.17
P/E ratio
N/A
FY2024 Revenue
$8.13M
EPS (H1 2026)
$-3.44
Gross Margin (FY2024)
N/A
Profit Margin (FY2024)
-908.72%
Beta
-0.11
Div yield
N/A
Sector
Healthcare
Climb Bio Inc (CLYM) is a biotechnology company listed on US.
Latest reported CLYM revenue for 2024-12-31 was $8.1M. Net income was -$73.9M. Revenue was up 76.0% from 2023-12-31 to 2024-12-31. CLYM currently screens at market cap $85.8M.
Use this CLYM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CLYM income, balance, and cash tables.
Climb Bio Inc (CLYM) is a biotechnology company in the Healthcare sector.
Latest cached Climb Bio Inc (CLYM) revenue for Dec 31, 2024 was $8.1M. Net income was -$73.9M. Statements: https://lician.com/financials/clym
Climb Bio Inc (CLYM) market capitalization is $85.8M on the latest cached snapshot.
Climb Bio Inc (CLYM) cached previous close $11.07; day range $10.73 – $11.29; volume 685,708. Session quote: https://lician.com/quote/clym
Climb Bio Inc (CLYM) latest cached earnings event is "CLYM earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CLYM filing is 8-K · Sep 3, 2026. Filings: https://lician.com/sec/clym